BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28766108)

  • 1. A Pharmacoepidemiology Database System for Monitoring Risk Due to the Use of Medicines by New Zealand Primary Care Patients.
    Tomlin AM; Reith DM; Woods DJ; Lloyd HS; Smith A; Fountain JS; Tilyard MW
    Drug Saf; 2017 Dec; 40(12):1259-1277. PubMed ID: 28766108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethnic inequality in non-steroidal anti-inflammatory drug-associated harm in New Zealand: A national population-based cohort study.
    Tomlin A; Woods DJ; Lambie A; Eskildsen L; Ng J; Tilyard M
    Pharmacoepidemiol Drug Saf; 2020 Aug; 29(8):881-889. PubMed ID: 32476226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re-prescribing of causative drugs in persons discharged after serious drug-induced upper gastrointestinal bleeding.
    Dall M; dePont Christensen R; Schaffalitzky de Muckadell OB; Lassen AT; Hallas J
    Aliment Pharmacol Ther; 2012 Apr; 35(8):948-54. PubMed ID: 22313346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upper gastrointestinal bleeding associated with NSAIDs, other drugs and interactions: a nested case-control study in a new general practice database.
    de Abajo FJ; Gil MJ; Bryant V; Timoner J; Oliva B; García-Rodríguez LA
    Eur J Clin Pharmacol; 2013 Mar; 69(3):691-701. PubMed ID: 22955795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empirical assessment of case-based methods for identification of drugs associated with upper gastrointestinal bleeding in the French National Healthcare System database (SNDS).
    Thurin NH; Lassalle R; Schuemie M; Pénichon M; Gagne JJ; Rassen JA; Benichou J; Weill A; Blin P; Moore N; Droz-Perroteau C
    Pharmacoepidemiol Drug Saf; 2020 Aug; 29(8):890-903. PubMed ID: 32524701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding?
    Tata LJ; Fortun PJ; Hubbard RB; Smeeth L; Hawkey CJ; Smith CJ; Whitaker HJ; Farrington CP; Card TR; West J
    Aliment Pharmacol Ther; 2005 Aug; 22(3):175-81. PubMed ID: 16091054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods for retrospective detection of drug safety signals and adverse events in electronic general practice records.
    Tomlin A; Reith D; Dovey S; Tilyard M
    Drug Saf; 2012 Sep; 35(9):733-43. PubMed ID: 22861670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation study in four health-care databases: upper gastrointestinal bleeding misclassification affects precision but not magnitude of drug-related upper gastrointestinal bleeding risk.
    Valkhoff VE; Coloma PM; Masclee GM; Gini R; Innocenti F; Lapi F; Molokhia M; Mosseveld M; Nielsson MS; Schuemie M; Thiessard F; van der Lei J; Sturkenboom MC; Trifirò G;
    J Clin Epidemiol; 2014 Aug; 67(8):921-31. PubMed ID: 24794575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents.
    de Abajo FJ; García-Rodríguez LA
    Arch Gen Psychiatry; 2008 Jul; 65(7):795-803. PubMed ID: 18606952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant Use of NSAIDs or SSRIs with NOACs Requires Monitoring for Bleeding.
    Lee MT; Park KY; Kim MS; You SH; Kang YJ; Jung SY
    Yonsei Med J; 2020 Sep; 61(9):741-749. PubMed ID: 32882758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Empirical assessment of case-based methods for drug safety alert identification in the French National Healthcare System database (SNDS): Methodology of the ALCAPONE project.
    Thurin NH; Lassalle R; Schuemie M; Pénichon M; Gagne JJ; Rassen JA; Benichou J; Weill A; Blin P; Moore N; Droz-Perroteau C
    Pharmacoepidemiol Drug Saf; 2020 Sep; 29(9):993-1000. PubMed ID: 32133717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study.
    de Abajo FJ; Rodríguez LA; Montero D
    BMJ; 1999 Oct; 319(7217):1106-9. PubMed ID: 10531103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of serious upper gastrointestinal events with concurrent use of NSAIDs and SSRIs: a case-control study in the general population.
    Helin-Salmivaara A; Huttunen T; Grönroos JM; Klaukka T; Huupponen R
    Eur J Clin Pharmacol; 2007 Apr; 63(4):403-8. PubMed ID: 17347805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the New Zealand Intensive Medicines Monitoring Programme in identification of previously unrecognised signals of adverse drug reactions.
    Clark DW; Harrison-Woolrych M
    Curr Drug Saf; 2006 May; 1(2):169-78. PubMed ID: 18690928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Confounding adjustment via a semi-automated high-dimensional propensity score algorithm: an application to electronic medical records.
    Toh S; García Rodríguez LA; Hernán MA
    Pharmacoepidemiol Drug Saf; 2011 Aug; 20(8):849-57. PubMed ID: 21717528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective serotonin reuptake inhibitors are associated with a modest increase in the risk of upper gastrointestinal bleeding.
    Targownik LE; Bolton JM; Metge CJ; Leung S; Sareen J
    Am J Gastroenterol; 2009 Jun; 104(6):1475-82. PubMed ID: 19491861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poor awareness of preventing aspirin-induced gastrointestinal injury with combined protective medications.
    Zhu LL; Xu LC; Chen Y; Zhou Q; Zeng S
    World J Gastroenterol; 2012 Jun; 18(24):3167-72. PubMed ID: 22791953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoxetine and Risk of Bleeding in Patients Aged 60 Years and Older Using the Korea Adverse Event Reporting System Database: A Case/Noncase Study.
    Kim S; Ko YJ; Park K; Yang BR; Kim MS; Park BJ
    J Clin Psychopharmacol; 2019; 39(4):362-366. PubMed ID: 31206390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal toxicity among patients taking selective COX-2 inhibitors or conventional NSAIDs, alone or combined with proton pump inhibitors: a case-control study.
    Bakhriansyah M; Souverein PC; de Boer A; Klungel OH
    Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1141-1148. PubMed ID: 28370857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying drug combinations associated with acute kidney injury using association rules method.
    Nishtala PS; Chyou TY
    Pharmacoepidemiol Drug Saf; 2020 Apr; 29(4):467-473. PubMed ID: 32080933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.